Kinetics of the Factor XIa catalyzed activation of human blood coagulation Factor IX. 1984

P N Walsh, and H Bradford, and D Sinha, and J R Piperno, and G P Tuszynski

The kinetics of activation of human Factor IX by human Factor XIa was studied by measuring the release of a trichloroacetic acid-soluble tritium-labeled activation peptide from Factor IX by a modification of a method described for bovine Factor IX activation by Zur and Nemerson (Zur, M., and Y. Nemerson, 1980, J. Biol. Chem., 255:5703-5707). Initial rates of trichloroacetic acid-soluble 3H-release were linear over 10-30 min of incubation of Factor IX (88 nM) with CaCl2 (5 mM) and with pure (greater than 98%) Factor XIa (0.06-1.3 nM), which was prepared by incubating human Factor XI with bovine Factor XIIa. Release of 3H preceded the appearance of Factor IXa activity, and the percentage of 3H released remained constant when the mole fraction of 3H-labeled and unlabeled Factor IX was varied and the total Factor IX concentration remained constant. A linear correlation (r greater than 0.98, P less than 0.001) was observed between initial rates of 3H-release and the concentration of Factor XIa, measured by chromogenic assay and by radioimmunoassay and added at a Factor IX:Factor XIa molar ratio of 70-5,600. Kinetic parameters, determined by Lineweaver-Burk analysis, include Km (0.49 microM) of about five- to sixfold higher than the plasma Factor IX concentration, which could therefore regulate the reaction. The catalytic constant (kcat) (7.7/s) is approximately 20-50 times higher than that reported by Zur and Nemerson (Zur, M., and Y. Nemerson, 1980, J. Biol. Chem., 255:5703-5707) for Factor IX activation by Factor VIIa plus tissue factor. Therefore, depending on the relative amounts of Factor XIa and Factor VIIa generated in vivo and other factors which may influence reaction rates, these kinetic parameters provide part of the information required for assessing the relative contributions of the intrinsic and extrinsic pathways to Factor IX activation, and suggest that the Factor XIa catalyzed reaction is physiologically significant.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D005164 Factor IX Storage-stable blood coagulation factor acting in the intrinsic pathway of blood coagulation. Its activated form, IXa, forms a complex with factor VIII and calcium on platelet factor 3 to activate factor X to Xa. Deficiency of factor IX results in HEMOPHILIA B (Christmas Disease). Autoprothrombin II,Christmas Factor,Coagulation Factor IX,Plasma Thromboplastin Component,Blood Coagulation Factor IX,Factor 9,Factor IX Complex,Factor IX Fraction,Factor Nine,Factor IX, Coagulation
D005172 Factor XI Stable blood coagulation factor involved in the intrinsic pathway. The activated form XIa activates factor IX to IXa. Deficiency of factor XI is often called hemophilia C. Coagulation Factor XI,Plasma Thromboplastin Antecedent,Blood Coagulation Factor XI,Factor 11,Factor Eleven,Antecedent, Plasma Thromboplastin,Factor XI, Coagulation,Thromboplastin Antecedent, Plasma
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014316 Tritium The radioactive isotope of hydrogen also known as hydrogen-3. It contains two NEUTRONS and one PROTON in its nucleus and decays to produce low energy BETA PARTICLES. Hydrogen-3,Hydrogen 3
D015945 Factor XIa Activated form of factor XI. In the intrinsic pathway, Factor XI is activated to XIa by factor XIIa in the presence of cofactor HMWK; (HIGH MOLECULAR WEIGHT KININOGEN). Factor XIa then activates factor IX to factor IXa in the presence of calcium. Coagulation Factor XIa,Factor XI, Activated,Activated Factor XI,Blood Coagulation Factor XI, Activated,Contact Activation Product,Factor 11A,Factor Eleven A,Factor XIa, Coagulation

Related Publications

P N Walsh, and H Bradford, and D Sinha, and J R Piperno, and G P Tuszynski
July 1986, Blood,
P N Walsh, and H Bradford, and D Sinha, and J R Piperno, and G P Tuszynski
March 2008, The Journal of biological chemistry,
P N Walsh, and H Bradford, and D Sinha, and J R Piperno, and G P Tuszynski
July 2000, Trends in cardiovascular medicine,
P N Walsh, and H Bradford, and D Sinha, and J R Piperno, and G P Tuszynski
December 2013, Journal of thrombosis and haemostasis : JTH,
P N Walsh, and H Bradford, and D Sinha, and J R Piperno, and G P Tuszynski
June 1987, Biochemistry,
P N Walsh, and H Bradford, and D Sinha, and J R Piperno, and G P Tuszynski
August 2005, Biochemistry,
P N Walsh, and H Bradford, and D Sinha, and J R Piperno, and G P Tuszynski
August 2009, Journal of thrombosis and haemostasis : JTH,
P N Walsh, and H Bradford, and D Sinha, and J R Piperno, and G P Tuszynski
October 1982, Thrombosis and haemostasis,
P N Walsh, and H Bradford, and D Sinha, and J R Piperno, and G P Tuszynski
July 2010, Journal of thrombosis and haemostasis : JTH,
P N Walsh, and H Bradford, and D Sinha, and J R Piperno, and G P Tuszynski
May 2014, Thrombosis research,
Copied contents to your clipboard!